Copyright
©The Author(s) 2015.
World J Pharmacol. Jun 9, 2015; 4(2): 168-171
Published online Jun 9, 2015. doi: 10.5497/wjp.v4.i2.168
Published online Jun 9, 2015. doi: 10.5497/wjp.v4.i2.168
Active angiogenesis and high vascular density |
Extensive production of vascular mediators that facilitate extraravasation |
Bradykinin |
Nitric oxide |
Vascular permeability factor/vascular endothelial growth factor |
Prostaglandins |
Collagenase (matrix metalloproteinases, or MMPs) |
Peroxynitrite |
Defective vascular architecture, for example, lack of smooth muscle layer cells, lack of or fewer receptors for angiotensin II, large gap in endothelial cell-cell junctions, anomalous conformation of tumor vasculature (e.g., branching or stretching) |
Impaired lymphatic clearance of macromolecules and lipids from interstitial tissue (→ prolonged retention of these substances) |
- Citation: Fang J. Enhanced permeability and retention effect based nanomedicine, a solution for cancer. World J Pharmacol 2015; 4(2): 168-171
- URL: https://www.wjgnet.com/2220-3192/full/v4/i2/168.htm
- DOI: https://dx.doi.org/10.5497/wjp.v4.i2.168